Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giuseppe Lopalco

Showing results (61-70 of 221) with videos related to

Pageof 23
Sort By:
Frontiers in Immunology|March 15, 2017
Cytokine Signatures in Mucocutaneous and Ocular Behçet's DiseaseGiuseppe Lopalco, Orso Maria Lucherini, Antonio Lopalco, et al.
Rheumatology International|July 29, 2017
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative reviewJurgen Sota, Donato Rigante, Giuseppe Lopalco, et al.
Internal and Emergency Medicine|April 11, 2018
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonismAntonio Brucato, Giacomo Emmi, Luca Cantarini, et al.
Internal and Emergency Medicine|September 3, 2021
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infectionMichele Barone, Vincenzo Venerito, Rosa Paolillo, et al.
The Israel Medical Association Journal : IMAJ|May 28, 2016
Efficacy and Safety of Intravenous Immunoglobulin Treatment in Refractory Behcet's Disease with Different Organ Involvement: A Case SeriesLuca Cantarini, Maria L Stromillo, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|May 27, 2020
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literatureRoberto Giacomelli, Jurgen Sota, Piero Ruscitti, et al.
Mediators of Inflammation|February 18, 2017
Update on the Medical Management of Gastrointestinal Behçet's DiseaseGiuseppe Lopalco, Donato Rigante, Vincenzo Venerito, et al.
Rheumatology International|February 26, 2019
The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic reviewAlessandra Bettiol, Elena Silvestri, Gerardo Di Scala, et al.
Journal of Clinical Medicine|December 6, 2018
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk FactorsMichele Barone, Maria Teresa Viggiani, Maria Grazia Anelli, et al.
Trends in Cardiovascular Medicine|May 8, 2020
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatmentGiuseppe Lopalco, Donato Rigante, Luca Cantarini, et al.
Pageof 23

Showing results (61-70 of 221) with videos related to

Sort By:
Pageof 23
Frontiers in Immunology|March 15, 2017
Cytokine Signatures in Mucocutaneous and Ocular Behçet's DiseaseGiuseppe Lopalco, Orso Maria Lucherini, Antonio Lopalco, et al.
Rheumatology International|July 29, 2017
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative reviewJurgen Sota, Donato Rigante, Giuseppe Lopalco, et al.
Internal and Emergency Medicine|April 11, 2018
Management of idiopathic recurrent pericarditis in adults and in children: a role for IL-1 receptor antagonismAntonio Brucato, Giacomo Emmi, Luca Cantarini, et al.
Internal and Emergency Medicine|September 3, 2021
Long-term safety of rituximab in rheumatic patients with previously resolved hepatitis B virus infectionMichele Barone, Vincenzo Venerito, Rosa Paolillo, et al.
The Israel Medical Association Journal : IMAJ|May 28, 2016
Efficacy and Safety of Intravenous Immunoglobulin Treatment in Refractory Behcet's Disease with Different Organ Involvement: A Case SeriesLuca Cantarini, Maria L Stromillo, Antonio Vitale, et al.
Clinical and Experimental Rheumatology|May 27, 2020
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literatureRoberto Giacomelli, Jurgen Sota, Piero Ruscitti, et al.
Mediators of Inflammation|February 18, 2017
Update on the Medical Management of Gastrointestinal Behçet's DiseaseGiuseppe Lopalco, Donato Rigante, Vincenzo Venerito, et al.
Rheumatology International|February 26, 2019
The right place of interleukin-1 inhibitors in the treatment of Behçet's syndrome: a systematic reviewAlessandra Bettiol, Elena Silvestri, Gerardo Di Scala, et al.
Journal of Clinical Medicine|December 6, 2018
Sarcopenia in Patients with Rheumatic Diseases: Prevalence and Associated Risk FactorsMichele Barone, Maria Teresa Viggiani, Maria Grazia Anelli, et al.
Trends in Cardiovascular Medicine|May 8, 2020
The autoinflammatory side of recurrent pericarditis: Enlightening the pathogenesis for a more rational treatmentGiuseppe Lopalco, Donato Rigante, Luca Cantarini, et al.
Pageof 23